Drug Substance Analysis

Therapeutic Vaccines Target Cancer and Other Viral-Induced Diseases

November 15, 2017

The use of therapeutic vaccines presents a new way to manage diseases, such as cancer and sexually transmitted diseases.

Nitto Avecia Completes Large-Scale Synthesis of Oligonucleotide

November 13, 2017

PTSM: Pharmaceutical Technology Sourcing and Management

Company completes first successful run of what is believed to be the largest synthesis-scale done for oligonucleotide APIs.

WuXi and Pall Establish Continuous MAb Manufacture

November 13, 2017

The companies have established a joint laboratory to develop full continuous processing to manufacture high yields of monoclonal antibodies at reduced costs.

AstraZeneca Gets Positive EMA Opinion on Respiratory Biologic

November 10, 2017

The EMA’s Committee for Medicinal Products for Human Use has recommended marketing authorization approval for AstraZeneca’s benralizumab, a monoclonal antibody for treating severe asthma.

Dynavax Wins FDA Approval for Hep B Vaccine

November 10, 2017

The company expects to commercially launch the new vaccine in the US in the first quarter of 2018.

Celonic Acquires Glycotope’s Biomanufacturing Facility

November 03, 2017

CDMO Celonic acquired a biomanufacturing facility in Heidelberg, Germany from Glycotope.

Catalent and Grid Therapeutics Form Immuno-Oncology Pact

November 02, 2017

The companies will collaborate to develop and manufacture Grid’s lead therapeutic candidate for the treatment of solid tumors.

PTSM: Pharmaceutical Technology Sourcing and Management